Clinical Trials Browser

Phase 2 × OTHER × icotinib × Clear all

NCT02264210 2024-09-25

CORIN

Phase 2 Completed

128 enrolled 9 charts

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06517953 2024-07-25

IcomBine

Phase 2 Recruiting

Non-small Cell Lung Cancer Metastatic

NCT05514314 2022-08-24

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05132985 2021-12-10

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03736837 2021-03-15

ALTER-L004

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT03151161 2018-06-07

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 2 Unknown

Lung Neoplasms

NCT01963195 2017-05-08

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

Phase 2 Unknown

Drug-Related Side Effects and Adverse Reactions

NCT03123484 2017-04-21

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02738983 2016-04-14

RT Plus EGFR-TKI for Wild-type NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02375581 2016-03-22

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02430974 2015-04-30

Chemotherapy of NSCLC With or Without Icotinib

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02407366 2015-04-02

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Phase 2 Unknown

Lung Neoplasms

NCT02009605 2015-03-05

Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer

Phase 2 Unknown

Squamous Cell Carcinoma of Lung

NCT02272127 2014-10-22

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

Phase 2 Unknown

NSCLC

NCT02191059 2014-07-31

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

Phase 2 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01688713 2012-09-20

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

Phase 2 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung